<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Src and Syk kinase attenuation of HIV infection</title>
	<atom:link href="http://walkerma.wordpress.com/2007/03/21/src-and-syk-kinase-attenuation-of-hiv-infection/feed/" rel="self" type="application/rss+xml" />
	<link>http://walkerma.wordpress.com/2007/03/21/src-and-syk-kinase-attenuation-of-hiv-infection/</link>
	<description>A medicinal chemist searching for that needle in a haystack</description>
	<pubDate>Wed, 20 Aug 2008 12:00:44 +0000</pubDate>
	<generator>http://wordpress.org/?v=MU</generator>
		<item>
		<title>By: Wavefunction</title>
		<link>http://walkerma.wordpress.com/2007/03/21/src-and-syk-kinase-attenuation-of-hiv-infection/#comment-229</link>
		<dc:creator>Wavefunction</dc:creator>
		<pubDate>Sat, 07 Apr 2007 13:52:21 +0000</pubDate>
		<guid isPermaLink="false">http://walkerma.wordpress.com/2007/03/21/src-and-syk-kinase-attenuation-of-hiv-infection/#comment-229</guid>
		<description>Piceatonnol looks a &lt;i&gt;lot&lt;/i&gt; like resveratrol the wine molecule. I wonder if res also inhibit these (or other) kinases.</description>
		<content:encoded><![CDATA[<p>Piceatonnol looks a <i>lot</i> like resveratrol the wine molecule. I wonder if res also inhibit these (or other) kinases.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: walkerma</title>
		<link>http://walkerma.wordpress.com/2007/03/21/src-and-syk-kinase-attenuation-of-hiv-infection/#comment-216</link>
		<dc:creator>walkerma</dc:creator>
		<pubDate>Thu, 05 Apr 2007 16:32:55 +0000</pubDate>
		<guid isPermaLink="false">http://walkerma.wordpress.com/2007/03/21/src-and-syk-kinase-attenuation-of-hiv-infection/#comment-216</guid>
		<description>Structure corrected...there were no structures, chemical-formulas or references given for PP2, so I had to rely on what SciFinder gave.

Virology is my field, not kinases...even so, I would have like to see them use more-active/selective agents. The title of the paper promises more than the experiments were able to deliver.</description>
		<content:encoded><![CDATA[<p>Structure corrected&#8230;there were no structures, chemical-formulas or references given for PP2, so I had to rely on what SciFinder gave.</p>
<p>Virology is my field, not kinases&#8230;even so, I would have like to see them use more-active/selective agents. The title of the paper promises more than the experiments were able to deliver.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: kinasepro</title>
		<link>http://walkerma.wordpress.com/2007/03/21/src-and-syk-kinase-attenuation-of-hiv-infection/#comment-215</link>
		<dc:creator>kinasepro</dc:creator>
		<pubDate>Thu, 05 Apr 2007 01:45:22 +0000</pubDate>
		<guid isPermaLink="false">http://walkerma.wordpress.com/2007/03/21/src-and-syk-kinase-attenuation-of-hiv-infection/#comment-215</guid>
		<description>I don't know anything about CD4+ translation of the yadda yadda yadda, but far be it from me to let a blog entry on Kinase inhibitors go un-besmirched!  I do pretend to know a thing or two about them in the chemblogosphere after all.

So...  Well...  first fix structure plz: PP2 is ClC1=CC=C(C2=NN(C(C)(C)C)C3=C2C(N)=NC=N3)C=C1 

Second... Hmmm well, paper's interesting I guess.  I take it to say: kinases may be involved.  But frankly - PP2 hits tons of kinases, mostly in the SRC family, but a number outside as well like ckit, and even abl, so isn't it a bit hard to make any conclusions about target? (not so much your conclusions, but those in the paper) Also piceatannol is only about 1 uM @ Km on SYK.  I don't know anything about the selectivity of the latter - but certainly the non-kinase activity would be relevant to the article.

I would put money on Ariad having some insanely selective SRC inhibitors and a collaboration using one of their compounds to investigate the theory would certainly be interesting... PP2?  Umm...  Not so much.  Likewise with somebody like Rigel and SYK.  I guess I'm just not impressed with their choice of inhibitors.

Personally, I blame the French.</description>
		<content:encoded><![CDATA[<p>I don&#8217;t know anything about CD4+ translation of the yadda yadda yadda, but far be it from me to let a blog entry on Kinase inhibitors go un-besmirched!  I do pretend to know a thing or two about them in the chemblogosphere after all.</p>
<p>So&#8230;  Well&#8230;  first fix structure plz: PP2 is ClC1=CC=C(C2=NN(C(C)(C)C)C3=C2C(N)=NC=N3)C=C1 </p>
<p>Second&#8230; Hmmm well, paper&#8217;s interesting I guess.  I take it to say: kinases may be involved.  But frankly - PP2 hits tons of kinases, mostly in the SRC family, but a number outside as well like ckit, and even abl, so isn&#8217;t it a bit hard to make any conclusions about target? (not so much your conclusions, but those in the paper) Also piceatannol is only about 1 uM @ Km on SYK.  I don&#8217;t know anything about the selectivity of the latter - but certainly the non-kinase activity would be relevant to the article.</p>
<p>I would put money on Ariad having some insanely selective SRC inhibitors and a collaboration using one of their compounds to investigate the theory would certainly be interesting&#8230; PP2?  Umm&#8230;  Not so much.  Likewise with somebody like Rigel and SYK.  I guess I&#8217;m just not impressed with their choice of inhibitors.</p>
<p>Personally, I blame the French.</p>
]]></content:encoded>
	</item>
</channel>
</rss>
